The aim of this study was to assess the clinical effectiveness of Hydroxychloroquine-based regimens versus standard treatment in patients with the coronavirus disease admitted in …
J Bajpai, A Pradhan, A Singh - indian journal of tuberculosis, 2020 - Elsevier
COVID 19 infection is unarguably the worst pandemic of this century. Till date there is no promising drug and vaccine available to treat this deadly viral infection. In the early phase …
T Gupta, P Thakkar, B Kalra… - Reviews in medical …, 2022 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) caused by the novel severe acute respiratory syndrome coronavirus 2 continues to grow and spread throughout the world …
The novel coronavirus SARS-CoV-2, causing the disease COVID-19, first emerged in Wuhan, China in December 2019 and has now spread to 203 countries or territories …
Objective The pandemic coronavirus disease‐19 (COVID‐19) has pushed the global healthcare system to a crisis and amounted to a huge economic burden. Different drugs for …
RR Shah - Journal of clinical pharmacy and therapeutics, 2021 - Wiley Online Library
What is known and Objective Non‐clinical studies suggest that chloroquine (CQ) and hydroxychloroquine (HCQ) have antiviral activities. Early clinical reports of successful HCQ …
Abstract Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment …
Z Kashour, T Kashour, D Gerberi… - Clinical and …, 2021 - Wiley Online Library
Many meta‐analyses have been published about the efficacy of hydroxychloroquine (HCQ) in coronavirus disease 2019 (COVID‐19). Most of them included observational studies, and …
F Mazhar, MA Hadi, CS Kow, AMN Marran… - International Journal of …, 2020 - Elsevier
Objectives We critically evaluated the quality of evidence and quality of harm reporting in clinical trials that evaluated the effectiveness of hydroxychloroquine (HCQ) or chloroquine …